Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What is the Projected CAGR for the Glomerulonephritis Market Size from 2025 to 2034?
The market size for glomerulonephritis has seen considerable growth in recent times. The market is set to expand from $11.06 billion in 2024 to $11.64 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.3%. Historic period growth has been driven by a surge in kidney disorders, the rise in post-streptococcal glomerulonephritis infections, an upswing in research and development and an increase in kidney failure incidence. Growing awareness about kidney diseases is also contributing to this growth.
Robust expansion is predicted for the glomerulonephritis market in the upcoming years, escalating to $14.14 billion by 2029 with a compound annual growth rate (CAGR) of 5.0%. The anticipated growth during this period is attributed to factors such as rising instances of diabetes, an aged population, increased healthcare spending, a growing number of dialysis patients, and an escalation in autoimmune disease cases. Key trend projections for this period comprise the introduction of new treatments and therapy methods, advancements in diagnostic technology, innovative therapeutics and treatments, inter-company collaboration, and intravenous immunoglobulin therapy.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21193&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Glomerulonephritis Market?
The growth of the glomerulonephritis market is anticipated to be fueled by the escalating incidences of kidney disorders. Kidney disorders encompass a spectrum of conditions that impact the kidneys’ structure or function, resulting in hindered filtration, waste elimination, and fluid regulation. The escalating incidences of kidney disorders can be attributed to factors like aging demographics, increasing instances of chronic ailments such as diabetes and hypertension, and lifestyle decisions. Kidney disorders spur glomerulonephritis by instigating disorders of the immune system, persistent inflammation, or structural harm, culminating in disrupted kidney filtration and performance. For example, the Australian Institute of Health and Welfare, a government agency based in Australia, revealed in December 2024 that mortality rates from chronic kidney disease (CKD) surged by 4.2% in 2021 and 6.2% in 2022. For the year 2021-22, nearly 2 million hospitalizations were attributed to CKD, accounting for 18% of all hospitalizations in Australia. Therefore, the escalating incidences of kidney disorders are anticipated to bolster the growth of the glomerulonephritis market.
Which Segments in the Glomerulonephritis Offer the Most Growth?
The glomerulonephritis market covered in this report is segmented –
1) By Type: Acute Glomerulonephritis, Chronic Glomerulonephritis
2) By Diagnosis: Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis
3) By Treatment: Medication, Surgery, Dialysis, Other Treatments
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Acute Glomerulonephritis: Post-infectious Glomerulonephritis, IgA Nephropathy, Lupus Nephritis, Rapidly Progressive Glomerulonephritis (RPGN), Goodpasture Syndrome
2) By Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Alport Syndrome, Diabetic Nephropathy, Hypertensive Nephrosclerosis
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21193&type=smp
What Are the Fastest-Growing Geographies in the How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Glomerulonephritis Market? Market?
North America was the largest region in the glomerulonephritis market in 2024. The regions covered in the glomerulonephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Glomerulonephritis Industry?
Significant players in the glomerulonephritis market are dedicating efforts towards the creation of progressive non-immunosuppressive solutions. This is in response to the unfulfilled medical needs and in pursuit of enhancing patient experiences. These non-immunosuppressive solutions represent therapies that neither suppress nor weaken the immune system, with the aim to manage conditions without negatively impacting the immune functions. For example, in September 2024, FILSPARI (sparsentan) was launched by US-based biopharmaceutical company, Travere Therapeutics Inc. This drug, having received FDA approval, is intended for treating IgA nephropathy, a type of kidney disease. Being the only non-immunosuppressive therapy proven to notably slow down kidney function deterioration in patients, FILSPARI’s approval is a monumental milestone in the treatment of IgA nephropathy. This is significant as IgA nephropathy is the most prevalent form of primary glomerulonephritis. This therapy extends an innovative choice for patients who previously had limited options. This progress demonstrates Travere Therapeutics Inc.’s dedication to enhancing patient experiences in kidney disease.
View the full report here:
https://www.thebusinessresearchcompany.com/report/glomerulonephritis-global-market-report
What Are the Key Elements That Define the Glomerulonephritis Market?
Glomerulonephritis is a kidney disorder characterized by inflammation of the glomeruli, the tiny filters in the kidneys that remove waste and excess fluids from the blood. It can result from infections, autoimmune diseases, or other underlying conditions, leading to symptoms such as blood in urine, proteinuria, and swelling. If left untreated, it may progress to chronic kidney disease or kidney failure.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21193
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model